← Back to guidelines
Nephrology4 papers

Dense deposit disease

Last edited: 4/16/2026

Overview

Dense deposit disease (DDD) is a rare form of glomerulonephritis characterized by the accumulation of dense, often complement-related deposits in the glomerular basement membrane, leading to progressive renal impairment 1.

Diagnosis

  • Novel diagnostic marker: Identification of large accumulations of apolipoprotein E in deposits via mass spectroscopy, confirmed by confocal microscopy and immunohistochemistry 1.
  • Complement pathway analysis: Evaluation of complement pathway components remains crucial for diagnosis 1.
  • Management

  • No specific first-line treatments mentioned in the provided abstracts.
  • Adjunctive therapies: Further research needed; current management likely involves supportive care and monitoring of renal function 1.
  • Special Populations

  • No specific data provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.
  • Key Recommendations

  • Incorporate apolipoprotein E assessment in diagnostic workup for DDD to enhance diagnostic accuracy (Evidence: Moderate) 1.
  • Continue monitoring complement pathway activity as part of clinical evaluation (Evidence: Expert opinion) 1.
  • Further clinical trials are needed to establish definitive treatment protocols beyond supportive care (Evidence: Expert opinion) 1.
  • References

    1 Alpers CE. Seeing through the density of dense deposit disease. Kidney international 2024. link

    Original source

    1. [1]
      Seeing through the density of dense deposit disease.Alpers CE Kidney international (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG